Asia Medical and Agricultural Laboratory and Research Center PCL(TH:AMARC)
฿2.88+0.12 (+4.35%)
TH:AMARC
Asia Medical and Agricultural Laboratory and Research Center PCL financials statements
฿2.88
At close:+0.12 (+4.35%)
Asia Medical and Agricultural Laboratory and Research Center PCL (AMARC) Ratios
Asia Medical and Agricultural Laboratory and Research Center PCL Ratios
TH:AMARC's free cash flow for Q2 2026 was ฿36.51M. For the 2026 fiscal year, TH:AMARC's free cash flow was decreased by ฿-5.76M and operating cash flow was ฿42.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.78 | 2.76 | 2.98 | 4.38 | 0.69 |
| Quick Ratio | 4.55 | 2.61 | 2.82 | 4.19 | 0.60 |
| Cash Ratio | 0.83 | 0.43 | 0.50 | 0.71 | 0.03 |
| Solvency Ratio | 1.75 | 0.67 | 0.35 | 0.32 | 0.23 |
| Operating Cash Flow Ratio | 3.81 | 1.13 | 0.69 | 0.81 | 0.80 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 13.72 | 3.60 |
| Net Current Asset Value | ฿ 147.63M | ฿ 73.60M | ฿ 60.82M | ฿ 139.07M | ฿ -173.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.06 | 0.11 | 0.14 | 0.39 |
| Debt-to-Equity Ratio | 0.03 | 0.07 | 0.13 | 0.17 | 0.82 |
| Debt-to-Capital Ratio | 0.03 | 0.07 | 0.12 | 0.15 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 |
| Financial Leverage Ratio | 1.19 | 1.23 | 1.26 | 1.28 | 2.12 |
| Debt Service Coverage Ratio | 206.20 | 45.14 | 17.49 | 5.38 | 2.22 |
| Interest Coverage Ratio | 161.52 | 22.76 | 5.57 | 3.91 | 4.99 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 |
| Interest Debt Per Share | 0.05 | 0.10 | 0.17 | 0.31 | 0.60 |
| Net Debt to EBITDA | -0.13 | 0.10 | 0.69 | 0.84 | 2.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.03% | 40.49% | 37.51% | 39.91% | 43.47% |
| EBIT Margin | 31.49% | 11.98% | 5.34% | 9.16% | 13.97% |
| EBITDA Margin | 39.95% | 23.67% | 18.16% | 21.89% | 25.76% |
| Operating Profit Margin | 31.49% | 11.98% | 5.46% | 9.16% | 13.97% |
| Pretax Profit Margin | 32.04% | 11.46% | 4.36% | 6.82% | 11.17% |
| Net Profit Margin | 32.29% | 11.56% | 3.33% | 5.51% | 10.11% |
| Continuous Operations Profit Margin | 32.29% | 11.56% | 3.45% | 5.51% | 10.11% |
| Net Income Per EBT | 100.80% | 100.85% | 76.46% | 80.89% | 90.48% |
| EBT Per EBIT | 101.74% | 95.61% | 79.95% | 74.41% | 79.95% |
| Return on Assets (ROA) | 22.13% | 6.22% | 1.49% | 2.08% | 5.55% |
| Return on Equity (ROE) | 26.34% | 7.66% | 1.88% | 2.65% | 11.74% |
| Return on Capital Employed (ROCE) | 23.37% | 7.24% | 2.71% | 3.81% | 9.64% |
| Return on Invested Capital (ROIC) | 22.96% | 6.98% | 1.96% | 2.92% | 7.66% |
| Return on Tangible Assets | 22.85% | 6.45% | 1.54% | 2.14% | 5.82% |
| Earnings Yield | 14.52% | 7.42% | 1.64% | 1.60% | 2.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.25 | 4.96 | 4.88 | 5.34 | 5.03 |
| Payables Turnover | 25.92 | 26.26 | 30.09 | 18.53 | 17.65 |
| Inventory Turnover | 17.64 | 18.77 | 17.87 | 13.05 | 18.36 |
| Fixed Asset Turnover | 1.27 | 0.90 | 0.73 | 0.73 | 0.72 |
| Asset Turnover | 0.69 | 0.54 | 0.45 | 0.38 | 0.55 |
| Working Capital Turnover Ratio | 2.97 | 2.72 | 1.64 | 2.70 | -15.57 |
| Cash Conversion Cycle | 118.89 | 79.19 | 83.08 | 76.62 | 71.74 |
| Days of Sales Outstanding | 112.27 | 73.64 | 74.78 | 68.33 | 72.54 |
| Days of Inventory Outstanding | 20.69 | 19.45 | 20.42 | 27.98 | 19.88 |
| Days of Payables Outstanding | 14.08 | 13.90 | 12.13 | 19.69 | 20.68 |
| Operating Cycle | 132.97 | 93.09 | 95.21 | 96.31 | 92.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.50 | 0.19 | 0.11 | 0.16 | 0.25 |
| Free Cash Flow Per Share | 0.38 | 0.13 | -0.03 | 0.10 | 0.18 |
| Dividend Paid and CapEx Coverage Ratio | 1.73 | 1.40 | 0.45 | 1.46 | 2.68 |
| Capital Expenditure Coverage Ratio | 4.20 | 3.38 | 0.77 | 2.47 | 3.69 |
| Operating Cash Flow Coverage Ratio | 9.94 | 2.07 | 0.66 | 0.56 | 0.42 |
| Operating Cash Flow to Sales Ratio | 0.43 | 0.23 | 0.16 | 0.20 | 0.30 |
| Free Cash Flow Yield | 14.58% | 10.42% | -2.29% | 3.50% | 6.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.84 | 13.47 | 60.87 | 62.61 | 34.98 |
| Price-to-Sales (P/S) Ratio | 2.22 | 1.56 | 2.03 | 3.45 | 3.54 |
| Price-to-Book (P/B) Ratio | 1.81 | 1.03 | 1.14 | 1.66 | 4.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.86 | 9.59 | -43.63 | 28.56 | 16.21 |
| Price-to-Operating Cash Flow Ratio | 5.23 | 6.75 | 12.96 | 16.98 | 11.82 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.04 | -1.26 | -1.35 | -0.53 |
| Enterprise Value Multiple | 5.44 | 6.68 | 11.88 | 16.61 | 16.42 |
| Enterprise Value | 1.07B | 545.60M | 624.18M | 957.22M | 1.04B |
| EV to EBITDA | 5.44 | 6.68 | 11.88 | 16.61 | 16.42 |
| EV to Sales | 2.17 | 1.58 | 2.16 | 3.64 | 4.23 |
| EV to Free Cash Flow | 6.70 | 9.74 | -46.31 | 30.08 | 19.39 |
| EV to Operating Cash Flow | 5.11 | 6.85 | 13.76 | 17.89 | 14.14 |
| Tangible Book Value Per Share | 1.38 | 1.19 | 1.17 | 1.61 | 0.64 |
| Shareholders’ Equity Per Share | 1.43 | 1.24 | 1.22 | 1.68 | 0.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | 0.24 | 0.19 | 0.10 |
| Revenue Per Share | 1.17 | 0.82 | 0.69 | 0.81 | 0.82 |
| Net Income Per Share | 0.38 | 0.09 | 0.02 | 0.04 | 0.08 |
| Tax Burden | 1.01 | 1.01 | 0.76 | 0.81 | 0.90 |
| Interest Burden | 1.02 | 0.96 | 0.82 | 0.74 | 0.80 |
| Research & Development to Revenue | 0.00 | 0.06 | 0.00 | 0.07 | 0.08 |
| SG&A to Revenue | 0.23 | 0.30 | 0.34 | 0.31 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.32 | 1.99 | 4.70 | 3.69 | 2.96 |
Currency in THB
